Meet the team

CEO &

Co-Founder

Pascal

Chief Operations 

Officer

Franziska

Clinical Operations

Team Leader

Vanja

Quality/Regulatory/Biostatistics

Team Leader

Samidha

Customer Solutions

Team Leader

Mohamed

Customer Engagement

Team Leader

Lucie

HR &

Finance

Barbara

Meet the team

CEO &

Co-Founder

Pascal

Chief Operations

Officer

Franziska

Clinical Operations

Team Leader

Vanja

Quality/RA/Biostatistics

Team Leader

Samidha

Customer Solutions

Team Leader

Mohamed

Customer Engagement

Team Leader

Lucie

HR &

Finance

Barbara

Board

President

Werner

Board

Paul

Board

Ricardo

Board

Pascal

Board

Peter

Board

President

Werner

Board

Paul

Board

Ricardo

Board

Pascal

Board

Peter

Investment Team

Hemex’s investment team consists of internal team committee members as well as external members and experts.

Investment Manager

Luana

Committtee

Paul

Committtee

Ralf

Committtee

Ricardo

Committtee

Thomas

Committtee

Werner

Investment Team

Hemex’s investment team consists of internal team committee members as well as external members and experts.

Investment Manager

Luana

Committtee

Paul

Committtee

Ralf

Committtee

Ricardo

Committtee

Thomas

Committtee

Werner

The HEMEX Story

2011

Paul Hadvary, Pascal Winnen and another co-founder started with the idea to support life science companies with Clinical, Quality and Regulatory services.

 

 

2015

HEMEX was incorporated in Liestal and has begun with its business operations in Switzerland and US.

 

 

2017

HEMEX Germany GmbH was established to facilitate easier access to the EU market.

 

 

2018

The US subsidiary was formed.

HEMEX Germany GmbH obtained a Certificate of GMP Compliance of a Manufacturer.

HEMEX AG obtained a Certificate of GDP Compliance by Swissmedic.

The company began with funding for pre- and seed-stage investments.

2019

HEMEX AG relocated to new facilities and expanded its offering with incubation services.

A cooperation agreement with Luoyang science and innovation park in Henan China was signed.

 

 

2020

HEMEX, BLKB and Launchpad formed a joint venture to launch an accelerator called inQbator.

2021

The exit of inQbator!

HEMEX closed the 2nd round of Series C with CHF 7.1 million.

The board is strengthened by new members. 

 

 

2022

HEMEX has obtained ISO 9001 and ISO 13485 certifications and started expanding its investment portfolio.

 

 

The HEMEX Story

2011

Paul Hadvary, Pascal Winnen and another co-founder started with the idea to support life science companies with Clinical, Quality and Regulatory services.

2015

HEMEX was incorporated in Liestal and has begun with its business operations in Switzerland and US.

2017

HEMEX Germany GmbH was established to facilitate easier access to the EU market.

2018

The US subsidiary was formed.

HEMEX Germany GmbH obtained a Certificate of GMP Compliance of a Manufacturer.

HEMEX AG obtained a Certificate of GDP Compliance by Swissmedic.

The company began with funding for pre- and seed-stage investments.

2019

HEMEX AG relocated to new facilities and expanded its offering with incubation services.

A cooperation agreement with Luoyang science and innovation park in Henan China was signed.

2020

HEMEX, BLKB and Launchpad formed a joint venture to launch an accelerator called inQbator.

2021

The exit of inQbator!

HEMEX closed the 2nd round of Series C with CHF 7.1 million.

The board is strengthened by new members. 

2022

HEMEX has obtained ISO 9001 and ISO 13485 certifications and started expanding its investment portfolio.

HEMEX in the media

Basellandschaftliche Kantonalbank lanciert neues Beratungsangebot für Start-ups

 

Die Basellandschaftliche Kantonalbank (BLKB) lanciert gemeinsam mit den Beratungsunternehmen HEMEX und Launchpad neue Beratungs- und Servicedienstleistungen für startups.

cash.ch

10.03.2021

HEMEX closes an oversubscribed Series C financing round

 

HEMEX, a bench-to-market Life Science consulting services- and investment firm, supported more than 30 companies in 2020 and has built offices in Europe, USA and Asia. The firm has closed an oversubscribed Series C financing round with significant contributions from Swiss entrepreneurs and private investors to accelerate its growth further.

startupticker.ch

10.02.2021

HEMEX attracts Swiss investors

 

A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for HEMEX. The biotech incubator will use the funds to accelerate its global expansion.

Basel Area Business & Innovation

11.02.2021

HEMEX gewinnt Schweizer Investoren

 

HEMEX, Kapitalgeber und Inkubator für Biotech Startups mit Sitz in Liestal, hat bei einer überzeichneten Finanzierungsrunde der Serie C einen nach eigenen Angaben substantiellen Betrag eingenommen. Er wurde ausschließlich von einer Gruppe privater Investoren aus der Schweiz aufgebracht.

Swiss Business Hub Germany

12.04.2021

EIC Pathfinder beneficiary HEMEX completes a €6.8 million Series C round

 

HEMEX, an EIC Pathfinder beneficiary company, has completed another fundraising round. After the first closing in February 2021, they secured a Series C round, increasing the amount to approximately €6.8 million (CHF 7.1 million).

European Innovation Council Community

06.12.2021

HEMEX erhält 7,1 Millionen Franken

 

Mit dem frischen Kapital will HEMEX, Partner der Standortförderung Basel Area Business & Innovation, Erstinvestitionen in die Frühphase von Start-ups finanzieren, die in den Life Sciences tätig sind. Außerdem plant das in Liestal ansässige Unternehmen, neue Team-Mitglieder für klinische Aktivitäten, Qualitätssicherung und Regulierungsangelegenheiten zu rekrutieren.

Swiss Business Hub Germany

14.02.2022

HEMEX in the media

Basellandschaftliche Kantonalbank lanciert neues Beratungsangebot für Start-ups

Die Basellandschaftliche Kantonalbank (BLKB) lanciert gemeinsam mit den Beratungsunternehmen Hemex und Launchpad neue Beratungs- und Servicedienstleistungen für startups.

cash.ch

10.03.2021

HEMEX closes an oversubscribed Series C financing round

HEMEX, a bench-to-market Life Science consulting services- and investment firm, supported more than 30 companies in 2020 and has built offices in Europe, USA and Asia. The firm has closed an oversubscribed Series C financing round with significant contributions from Swiss entrepreneurs and private investors to accelerate its growth further.

startupticker.ch

10.02.2021

HEMEX attracts Swiss investors

A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for HEMEX. The biotech incubator will use the funds to accelerate its global expansion.

Basel Area Business & Innovation

11.02.2021

HEMEX gewinnt Schweizer Investoren

HEMEX, Kapitalgeber und Inkubator für Biotech Startups mit Sitz in Liestal, hat bei einer überzeichneten Finanzierungsrunde der Serie C einen nach eigenen Angaben substantiellen Betrag eingenommen. Er wurde ausschließlich von einer Gruppe privater Investoren aus der Schweiz aufgebracht.

Swiss Business Hub Germany

12.04.2021

EIC Pathfinder beneficiary HEMEX completes a €6.8 million Series C round

HEMEX, an EIC Pathfinder beneficiary company, has completed another fundraising round. After the first closing in February 2021, they secured a Series C round, increasing the amount to approximately €6.8 million (CHF 7.1 million).

EIC Community

06.12.2021

HEMEX erhält 7,1 Millionen Franken

Mit dem frischen Kapital will HEMEX, Partner der Standortförderung Basel Area Business & Innovation, Erstinvestitionen in die Frühphase von Start-ups finanzieren, die in den Life Sciences tätig sind. Außerdem plant das in Liestal ansässige Unternehmen, neue Team-Mitglieder für klinische Aktivitäten, Qualitätssicherung und Regulierungsangelegenheiten zu rekrutieren.

Swiss Business Hub Germany

14.02.2022

How can we help?

Do you have specific inquires about any of our services? Would you like to know more about us? Or just stop by? Feel free to reach to us, we'd love to hear from you!

Hemex AG
Headquarters | Kasernenstrasse 30 | 4410 Liestal | Switzerland

Hemex Germany GmbH
c/o Loeba Treuhand GmbH, Wallbrunnstr. 24 | 79539 Loerrach | Germany 

Hemex, LLC
The 5th Floor |  3801 Avalon Park East Blvd, Suite 200 | Orlando, FL 32828 | USA

Hemex AG
info@hemex.ch
firstname.lastname@hemex.ch

Hemex Germany GmbH
info@hemex-germany.de
firstname.lastname@hemex-germany.de

Hemex, LLC
info@hemex-us.com
firstname.lastname@hemex-us.com

Switzerland:

Mo-Fri 09:00-17:00 CET, our headquarters can be reached on (+41) 61-927-28-00

Germany:

Mo-Fri 09:00-17:00 CET, our EU office can be reached on (+49) 1512-568-48-92

USA:

Mo-Fri 7 a.m. to 6 p.m. EST, our headquarters can be reached on (+1) 689-219-8929

Emergencies:

24/7/365 emergency phone numbers: 

(+41) 79-833-73-30 (Switzerland)

(+49) 1512-568-48-92 (Germany)

How can we help?

Do you have specific inquires about any of our services? Would you like to know more about us? Or just stop by? Feel free to reach to us, we'd love to hear from you!

Hemex AG
Headquarters | Kasernenstrasse 30 | 4410 Liestal | Switzerland

Hemex Germany GmbH
c/o Loeba Treuhand GmbH, Wallbrunnstr. 24 | 79539 Loerrach | Germany 

Hemex, LLC
The 5th Floor |  3801 Avalon Park East Blvd, Suite 200 | Orlando, FL 32828 | USA

Hemex AG
info@hemex.ch
firstname.lastname@hemex.ch

Hemex Germany GmbH
info@hemex-germany.de
firstname.lastname@hemex-germany.de

Hemex, LLC
info@hemex-us.com
firstname.lastname@hemex-us.com

Switzerland:

Mo-Fri 09:00-17:00 CET, our headquarters can be reached on (+41) 61-927-28-00

Germany:

Mo-Fri 09:00-17:00 CET, our EU office can be reached on (+49) 1512-568-48-92

USA:

Mo-Fri 7 a.m. to 6 p.m. EST, our headquarters can be reached on (+1) 689-219-8929

Emergencies:

24/7/365 emergency phone numbers: 

(+41) 79-833-73-30 (Switzerland)

(+49) 1512-568-48-92 (Germany)